3 FTSE Shares Hitting New Highs: Ashtead Group plc, AstraZeneca plc And easyJet plc

Ashtead Group plc (LON: AHT), AstraZeneca plc (LON: AZN) and easyJet plc (LON: EZJ) head up and up.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

So, did you think yesterday’s 82-point rise for the FTSE 100 (FTSEINDICES: ^FTSE) to 6,522 points signaled the start of a recovery? Well, think again — the index of top UK shares has already dipped back below 6,500, dropping 27 points to 6,495 by mid-morning. The punters appear to be nervous ahead of Wednesday’s US Federal Reserve decision on its economic policies, with many fearing recent upbeat US data will lead to an earlier-than-expected cutback in bond buying.

But even if the FTSE is a long way from breaking records, at least some individual shares are managing it. Here are three that are reaching new heights:

Ashtead

Ashtead Group (LSE: AHT) shares hit their highest closing price for 52 weeks yesterday, reaching 754.5p for a 12-month gain of more than 80% — and as I write, the price is unmoved from that level.

The equipment-rental firm reported impressive first-half results last week, with revenue up 23% and underlying pre-tax profit up a very nice 49%. Underlying earnings per share gained 50%, enabling the company to hike its interim dividend by a similar 50% to 2.25p per share.

The climb in Ashtead’s share price during 2013 has come at a cost, and there’s now a forward P/E based on current forecasts of nearly 18. That’s a tad higher then the FTSE average of around 14, and dividend yields are only around 1.4%. But there’s more EPS growth expected, with 2015 forecasts bringing the P/E down to 15.

AstraZeneca

AstraZeneca (LSE: AZN) (NYSE: AZN.US) also hit a new 52-week closing high yesterday, ending the day at 3,547.5p.

Today the price has fallen back a little to 3,532p, but that still leaves it more than 20% up over the past 12 months — and that’s not bad going for a FTSE 100 giant, especially when the index itself has managed less than half that.

AstraZeneca’s Q3 update was met with a favourable response from the market, and since then the firm has enjoyed good results from a couple of new drugs — an FDA Advisory Committee approval for one, and a successful Phase III trial for another.

easyJet

easyJet (LSE: EZJ) shares just won’t stop climbing — they have now more than doubled to reach a record close of 1,506p yesterday, and today the price is a quarter of a penny higher.

And even after such a dramatic rise, the shares are still only on a forward P/E of 14 — although some would say that’s too high, given the risky nature of airlines which are so critically dependent on fuel costs.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

> Alan does not own any shares mentioned in this article.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »